Fate Therapeutics
Fate develops programmed cellular immunotherapies for the treatment of metastatic cancer, traumatic injury and degenerative diseases.
Business Model:
Revenue: $69M
Employees: 201-500
Industries / Tags:
Detailed Fate Therapeutics Information
Geographic Data
Address: 3535 General Atomics Court
City: San Diego
State: CA
Zip: 92121
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$432M
Raised Total:$366M
Social
Metrics
2,454,874Website Global Rank
7,399Website Monthly Traffic
Twitter Followers
Description
Fate develops programmed cellular immunotherapies for the treatment of metastatic cancer, traumatic injury and degenerative diseases.
Contact Phone:
+18588751800
Contact Email:
Fate Therapeutics went public on 10/4/2013 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/4/2013
Ticker Symbol:
FATE
IPO Price:
$6/share
Amount Raised:
$40M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 4/2010 | Verio Therapeutics |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
